Yes, high doses of steroids definitively increase blood glucose levels.
High-dose systemic glucocorticoids cause hyperglycemia through multiple mechanisms including increased gluconeogenesis, reduced insulin sensitivity, impaired β-cell function, and altered adipokine signaling 1. This is a well-established adverse effect that occurs across all patient populations, whether or not they have pre-existing diabetes.
Mechanism and Clinical Pattern
Glucocorticoids produce a characteristic glucose pattern that differs from typical diabetes:
- Hyperglycemia predominantly occurs from midday onwards and in the evening
- Fasting morning glucose levels are often normal or near-normal 2
- This pattern reflects the timing of peak glucocorticoid effect on glucose metabolism
Evidence of Glucose Elevation
The magnitude of glucose elevation is dose-dependent and clinically significant:
- Daily corticosteroid dose significantly predicts higher blood glucose levels (rs=0.179, p=0.0095) 3
- In insulin-treated diabetic patients receiving high-dose perioperative steroids, median discharge glucose was 11.0 mmol/L versus 9.7 mmol/L in those not receiving high-dose steroids (p=0.011) 4
- Patients receiving larger corticosteroid doses experienced acute hyperglycemia, along with other metabolic complications including hypernatremia and hypokalemia 3
Incidence Across Populations
The frequency of glucocorticoid-induced diabetes varies by population:
- 15-52% in general non-autoimmune disease populations 1
- 10-26% in systemic lupus erythematosus patients 1
- 6% in polymyalgia rheumatica and 13% in giant cell arteritis 1
- 12.6% incidence among lupus patients after mean of 34 days of high-dose therapy 5
Key Risk Factors to Identify
Before initiating high-dose steroids, assess these specific risk factors 5, 1:
- Older age
- Higher BMI and central adiposity
- Hypertriglyceridemia
- Family history of diabetes
- Pre-existing diabetes or glucose intolerance
- Higher glucocorticoid dose and longer treatment duration
- Active inflammatory disease
Route-Specific Considerations
Oral glucocorticoids carry the greatest hyperglycemic risk, though intra-articular and intramuscular injections can also cause dysglycemia 1. The route of administration should factor into monitoring intensity.
Critical Clinical Implications
Monitoring Requirements
Glucose monitoring before starting therapy and during therapy is mandatory 5, particularly because:
- Individual differences in glucose tolerance and glucocorticoid response are substantial
- Pre-existing diabetes will worsen with steroid therapy 5
- The characteristic afternoon/evening hyperglycemia pattern may be missed by fasting glucose alone 2
Management Approach
The 2022 systematic review on glucocorticoid-induced hyperglycemia provides the most current guidance 6:
For patients with known diabetes:
- Calculate total daily insulin dose (TDD) at 0.5 units/kg
- Add NPH insulin (0.1-0.4 units/kg) timed with glucocorticoid administration
- The late peak and prolonged duration of NPH more closely matches the insulin resistance pattern from glucocorticoids
For new-onset glucocorticoid-associated diabetes:
- Do not immediately start basal-bolus insulin
- Begin with glucocorticoid-matched correctional insulin based on steroid type and dose (0.1-0.4 units/kg)
Common Pitfalls
- Relying solely on fasting glucose - This misses the characteristic afternoon/evening hyperglycemia pattern 2
- Underestimating insulin requirements - Body weight alone explains only a small proportion of dosing variance; sex, pre-existing diabetes status, and HbA1c also matter 7
- Failing to adjust insulin timing to steroid type - Different glucocorticoids have different durations of action requiring matched insulin profiles 6
Clinical Significance
Beyond glucose elevation itself, glucocorticoid-induced hyperglycemia is associated with:
- Increased mortality and morbidity 8
- Longer hospital length of stay (cumulative dose correlation: rs=0.679, p<0.0001) 3
- Increased risk of infections 5
- Cardiovascular events 9
The evidence is unequivocal: high-dose steroids increase blood glucose through well-defined mechanisms, requiring proactive screening and aggressive management to prevent serious complications 8, 9.